InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank93
3Y CAGR+81.0%
5Y CAGR+77.6%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+81.0%/yr
vs +55.7%/yr prior
5Y CAGR
+77.6%/yr
Recent acceleration
Acceleration
+25.2pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
17.7x
Strong expansion
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $3.24M | -7.5% |
| 2024 | $3.50M | +28.0% |
| 2023 | $2.73M | +400.6% |
| 2022 | $545889.00 | - |
| 2021 | $0.00 | -100.0% |
| 2020 | $183090.00 | +94.9% |
| 2019 | $93940.00 | +1.3% |
| 2018 | $92777.00 | - |
| 2017 | $0.00 | - |
| 2016 | $0.00 | - |